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A report from the 14th Genome Sequencing and Analysis
Conference, Boston, USA, 2-5 October 2002. 
At the heart of the 14th Genome Sequencing and Analysis
Conference, organized by The Institute for Genome
Research (TIGR), were a number of ways to tackle a problem
facing all avid readers - we know how to read, but which
books should we choose? One might read Tolstoy and
Flaubert until dawn and beyond, but neither wrote any
books explaining how to make chocolate brownies. In short,
reading sequence is like reading words, and now that we
know how to do it, the question (given the current costs) is
which genomes to read and why.
The meeting was opened by Barry Bloom (Harvard School
for Public Health, Boston, USA), who gave a provocative
reminder of how far we still have to go in our efforts to
combat infectious diseases in both rich and poor countries -
examples included the rapid rise in the developed world of
drug-resistant strains of Mycobacterium tuberculosis and
Staphylococcus aureus (60% of Japanese hospital cases are
multiply drug resistant), and the incredibly fast rise of drug-
resistant malaria strains in Africa. The hope, of course, is
that genomic approaches will prove valuable in understand-
ing pathogens and host-pathogen interactions and thus lead
to the development of novel drugs and therapies, and this is
already proving to be the case in the development of vac-
cines. In addition to the unquestionable humanitarian bene-
fits of providing adequate healthcare for the whole global
community (arguably a moral imperative), Bloom presented
a possible model of healthcare as investment, arguing that
the economic benefits arising from improved Third World
health more than outweigh the capital investment required.
As a stage-setting talk, it was ideal - the central message that
there is a huge amount more sequencing to be done was
clear, as was the reminder that while scientific interest is
important in determining future targets for sequencing, we
have a duty to bear in mind the usefulness of our work for
humanity at large, from Boston to Botswana.
More genomes, more species
The recurring question of what (or who) to sequence next is
in many ways the natural counterpart to the comparative
sequence analysis presentations that made up a substantial
part of the meeting: would chimp, baboon, bonobo and
orangutan sequence be ‘more useful’ than that of platypus,
chicken, dog and snake, for example. The answer of course
depends on the precise problem being addressed, a point
made very clearly by Eddy Rubin (Lawrence Berkeley
National Laboratory, Berkeley, USA). He illustrated two
examples of comparative sequence analysis, the first in
which human-murine comparison was perfectly sufficient to
identify a conserved regulatory element in the interleukin
gene cluster on human chromosome 5q31, and the second in
which the alignment of multiple primate sequences was
required to identify a novel apolipoprotein, apo(a). Thus,
while some questions can be answered with what we already
have, others will need a wider and deeper sampling of the
vertebrate genome pool. Eric Green (National Human
Genome Research Institute, Bethesda, USA) set out the
current NIH plans for sequencing non-human genomes,
including the genomes of chicken, dog, cow, several fish and,
perhaps most interestingly, several marsupials.
Although most comparative analyses focused on either analy-
sis of coding sequences or the identification of conserved reg-
ulatory elements, Victor Ambros (Dartmouth Medical School,
Hanover, USA) presented a computational approach to iden-
tifying non-coding microRNA genes - which encode smallnon-translated RNAs - in the nematode Caenorhabditis
elegans by comparison of C. elegans sequence with that of its
close relative Caenorhabditis briggsae. He estimates that
there are around 150 such genes in C. elegans, and that about
10% of those identified have human counterparts, suggesting
strongly that microRNAs are a widespread and common
mechanism of gene regulation.
C. elegans-C. briggsae sequence comparisons also featured
in the presentation by Andy Fire (Carnegie Institution of
Washington, USA), which focused on some of the many ways
in which hosts recognize their own genomes as distinct from
foreign nucleic acids. For a long time it was unclear why
transgenes become silenced in the C. elegans germline if
they are inserted within the context of foreign genomic DNA
(such as human sequence) rather than having coding regions
inserted into C. elegans genomic DNA. Careful sequence
analysis revealed that, unlike other available genomes, both
the C. elegans and C. briggsae genomes have a remarkably
regular phasing of AA/TT dinucleotides; Fire estimates that
as much as 1-2% of each genome is devoted to this phasing.
The observed phasing, which has a periodicity of 10 base-
pairs, leads to the assembly of a DNA helix which has a
markedly A/T-rich face; this is thought to be structurally dif-
ferent from a randomized genomic sequence. The signifi-
cance of this phasing to the silencing of genes in the
germline is confirmed by the finding that endogenous genes
that are transcriptionally active in the germline are ‘phased’,
whereas others are not. Thus, one way in which nematodes
may distinguish self from non-self at the level of an entire
chromosome may be a subtle structural difference in the
DNA helical conformation brought about by extended peri-
odicity in nucleotide sequence. Whether similar mechanisms
are used by other eukaryotes is not yet known, but this phe-
nomenon provides an intriguing example of the range of
genetic mechanisms uncovered through the careful analysis
of available genomic sequence.
Other highlights of the comparative sequence analysis talks
included the presentation by Kelly Frazer (Perlegen Sciences
Inc., Mountain View, USA) of a comparison of human and
chimp chromosome 21 using high-density oligonucleotide
arrays. Around 180 million 25mer oligonucleotides were
used to sample the non-repetitive chromosome 21 sequences
(making 22.5 Mb of the 33 Mb total), and the surprising
finding was that around 9% of human chromosome 21
sequences are deleted when comparison is made between
either human and chimp or human and baboon; further-
more, an amazingly large number, 35%, of the deletions are
in genic regions, suggesting that small rearrangements and
deletions may play a substantial role in genome evolution. 
Finally, there were also presentations in which comparative
analyses were used to reach beyond the identification of
individual functional elements (coding or non-coding), to
begin to describe entire gene networks. This approach was
illustrated by both Ed Marcotte (University of Texas, Austin,
USA) and Peer Bork (European Molecular Biology Labora-
tory, Heidelberg, Germany). Both groups used gene-fusion
data and phylogenetic profiles, along with genetic and physi-
cal interaction data, and microarray expression data, to
assemble complex network models of gene interaction and
function. Currently, such analyses are particularly useful in
prokaryotes, for which far more genome sequences are avail-
able; but as more metazoan genomes (and systematically
compiled functional data) become available, these computa-
tional ‘systems’ approaches look increasingly attractive.
In addition to the more general comparative analysis talks,
presentations were also made of the completed public
sequences for rat and mouse, by Richard Gibbs (Baylor
College of Medicine, Houston, USA) and Kerstin Lindblad-
Toh (Whitehead Institute for Biomedical Research, Cam-
bridge, USA), respectively. Mouse-human comparisons of
coding sequence suggest a lower human gene count than
previous estimates - somewhere in the order of 28,000
genes, for those with sweepstake tickets - and a full 80% of
human genes have a direct, single ortholog in mouse. There
appear to be 25 clusters of mouse-specific genes, the great
majority of which are involved in either reproduction (14
clusters) or immunity (5). Most interesting, perhaps, is the
finding that while only 1.5% of the mouse genome is thought
to be coding, models suggest that as much as 5% is under
detectable selection. The 3.5% of selected non-coding
sequence will clearly be fertile ground for future analysis. 
Other fully sequenced genomes presented at the meeting
included those of anthrax (Steven Salzberg, TIGR, Rockville,
USA) and the sea-squirt Ciona intestinalis (Daniel Rokhsar,
Department of Energy Joint Genome Institute, Walnut
Creek, USA). Sequence analysis of this invertebrate chor-
date sheds light on aspects of vertebrate evolution: there is
evidence for many ‘vertebrate-specific’ molecules (such as
claudins and noelin), including several that are involved in
the immune system (complement system components and
Toll-like receptors). In addition, there was strong sequence
evidence that Ciona has a cGMP-based light-sensing
cascade very similar to that of vertebrates. Whether we
sequence more vertebrates, more pathogens or more plants,
what is absolutely clear is that the quantity of raw sequence
data will continue to grow unabated in the foreseeable
future, and the insights from comparative sequence analysis
will grow accordingly. 
How Y stops the rot
Although comparative analyses of multiple genomes appear
to be the way of the future, there are still surprises hiding in
individual genomes. This was perhaps best illustrated by
David Page (Whitehead Institute for Biomedical Research)
who presented a startling new model for Y chromosome evo-
lution that arises from the newly available Y chromosome
2 Genome Biology Vol 3 No 12  Kemmer and Frasersequence. The Y chromosome contains approximately 24 Mb
of euchromatin (around 1% of the genome) and sequencing
is now nearly complete for this stretch, which contains not
only the extended region of close (greater than 99%) identity
between the X and Y chromosomes but also the euchromatic
portion of the so-called non-recombining region of Y (the
NRY). Page suggests that the NRY be rechristened the MSY -
the male-specific region of Y - for reasons that become
obvious. About 30% of the euchromatin in the MSY is
‘ampliconic’: that is, it has more than 99% sequence identity
to other MSY regions. But these ‘repeats’ are not low-com-
plexity short strings of bases: rather, they are lengthy
sequence duplications arranged as palindromes, with fully
25% of MSY euchromatin contained in eight palindromes
that range in size from 36 to 1,500 kilobases. Furthermore,
although the 18 single-copy MSY genes that have X
homologs are all outside the ampliconic regions, all 72 testis-
specific MSY genes are in amplicons. This clearly suggests
that the maintenance of Y-specific gene integrity is closely
associated with being in the amplicon palindromes, and led
Page to the amazing model that Y-specific genes are main-
tained by Y-Y gene conversion events within the Y amplicons
(or as one questioner paraphrased it “Y likes to have sex with
itself”). Thus, the Y chromosome is not merely some rotting
relic of an ancient autosome, but it is, rather, a specialized
chromosome that maintains the integrity of its genes
through unexpected intrachromosomal gene conversion
events, estimated to be as frequent as 1-2 per generation.
Clearly this model poses several major mechanistic ques-
tions, but as an illustration of the power of sequence analysis
to shed light on complex biology it takes some beating.
One genome at a time, or a whole ecological
niche?
As well as major efforts to sequence the complete genomes
of many organisms, one of the most intriguing possibilities
for current sequencing technologies is to generate essentially
random sequence reads in such a way as to sample the
genetic complexity of whole environments and in this way to
take a ‘sequence snapshot’ of an ecological niche. This can be
used not only to identify novel sequences belonging to hith-
erto unidentified species, but also to monitor how the
genetic diversity of a particular environment changes over
time. Sequencing could thus be a powerful way to check the
ecological pulse of fragile or poorly understood environ-
ments. This approach was beautifully illustrated in the back-
to-back talks of Edward DeLong (Monterey Bay Aquarium
Research Institute, USA) and David Relman (Stanford Uni-
versity, USA).
DeLong used ‘cultivation-independent’ genomic approaches
to study the vast spectrum of oceanic microbes, essentially
using random reads of total isolated microbial populations
from different local environments (for example, different
ocean depths). Among other examples, he identified both
archaebacteria and bacteria involved in anaerobic growth on
methane as a carbon source; these organisms were often
found to co-exist in structured syntropic aggregates. What
was key, however, was that the bacteria identified had never
been cultured in the lab, and such random-read approaches
provide an excellent window through which to explore
poorly understood organisms and ecologies. For Relman, the
environment being sampled was the human body and the
incredibly diverse range of microorganisms that live inside
each of us. Relman estimates that of the cells present in the
body only around 10% are human, with the remaining 90%
being bacterial. More surprising, however, is the richness of
strains. In just a single niche (for example, the subgingival
cavity, ‘between your teeth’) one can find evidence for
around 500 different species of bacteria, by using rRNA
sequence clustering. Furthermore, over 50% of the rRNA
sequences uncovered in this way had never been observed in
any cultured bacterial strains, illustrating both how little we
have yet sampled of possible genomes and also how
sequence sampling of ecological niches can provide a means
to investigate previously unanalyzed organisms.
In summary, the emerging picture from this meeting is that
we have only scratched the surface of genome sequences and
the insights that can be gained through sequence analysis.
Whether these insights emerge from the detailed analysis of
an individual genome, the comparison between the
sequences of multiple genomes, or the sampling of the
sequences present in whole ecological niches, sequencing
and sequence analysis will play a major role in the way we
approach biology for many years to come.
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